Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cholinergic Mechanisms of Attention in Aging
NCT04756232Phase 1Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Apr 2022
- Primary completion
- Apr 2025
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial (2 arms), sponsored by Vanderbilt University Medical Center. Primary endpoints: Proportion of participants who complete study visits with drug challenge and Proportion of participants who complete EEG. Started Apr 2022; status: completed.
Beyond the preview
Go deeper on NCT04756232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04756232.